
Alpha Teknova, Inc. (($TKNO)) has held its Q3 earnings call. Read on for the main highlights of the call. Teknova Earnings Call: Record Revenue, Stronger Outlook Teknova’s latest earnings call
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| TKNO | Alpha Teknova | 7.63 | 3.33 | 77.44% |
| Name | Price | % Change | |
|---|---|---|---|
| $7.63 | +77.44% |

Alpha Teknova, Inc. (($TKNO)) has held its Q3 earnings call. Read on for the main highlights of the call. Teknova Earnings Call: Record Revenue, Stronger Outlook Teknova’s latest earnings call

Reports Q3 revenue $12.7M, consensus $11.77M. “We posted record revenue for the second consecutive quarter,” said Stephen Gunstream, President and Chief Executive Officer at Teknova. “Growth was driven by increased

Consensus $46.01M. Matt Lowell, Teknova’s Chief Financial Officer, added, “We delivered excellent financial results in the third quarter 2026 compared to 2025, highlighted by 22% revenue growth and a significant

Alpha Teknova ( ($TKNO) ) has shared an update. On October 20, 2026, Alpha Teknova entered an underwriting agreement with TD Securities (USA) LLC and William Blair & Company for

TD Cowen and William Blair acted as joint book running managers for the offering. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Treasury yields retreated across the curve on Tuesday as weak U.S. housing data dented the perception of resilient economic growth. Rate-sensitive and defensive areas of the market outperformed, with Healthcare

The company said, “Teknova’s total revenue is estimated to be up 19% to 21% compared to the same period in the prior year. Teknova’s gross margin is estimated to have

Alpha Teknova (TKNO) announced that it has commenced an underwritten public offering of its common stock. All of the shares of common stock to be sold in the proposed offering

TD Cowen raised the firm’s price target on Alpha Teknova (TKNO) to $11 from $7 and keeps a Buy rating on the shares. The firm adjusted targets in the life

Alpha Teknova (TKNO) and Pluristyx announced that Pluristyx is completing a Type II Drug Master File for the PluriFreeze cryopreservation system for submission to the U.S. FDA. The DMF will
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Mar 16, 2027TBA | $491.27M | $-0.08 | $11.07M | 0.27 | -25.86 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.